Nuvation Bio Reports Preliminary Fourth Quarter And Full Year 2025 Financial Results And Provides 2026 Outlook Ahead Of 44Th Annual J.P. Morgan Healthcare Conference
Jan 12 (Reuters) - Nuvation Bio Inc NUVB.N:
NUVATION BIO REPORTS PRELIMINARY FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS AND PROVIDES 2026 OUTLOOK AHEAD OF 44TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
NUVATION BIO INC - PRELIM IBTROZI NET PRODUCT REVENUE $15.7 MILLION IN Q4
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.